TSS
ARTL icon

Two Sigma Securities’s Artelo Biosciences ARTL Stock Holding History

Two Sigma Securities’s Portfolio ARTL Stock Details ARTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-68
Closed -$8K – 2200
2022
Q1 		$8K Sell
68
-23
-25% -$2.64K ﹤0.01% 2050
2021
Q4 		$13K Buy
+91
New +$18K ﹤0.01% 1452

Other funds holding ARTL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCA
Snowden Capital Advisors New York $3.76B AUM 23.4% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
SG
StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return

Two Sigma Securities's ARTL Position: Q2 2022 in Review

Two Sigma Securities sold out of Artelo Biosciences (ARTL) in Q2 2022, closing a stake of 68 shares — an estimated $8K sold.

Two Sigma Securities first reported a position in ARTL in Q4 2021 and held it in 2 quarters. The position peaked at $13K in Q4 2021. 15 funds tracked by Wall St. Rank hold ARTL as of Q2 2022.

  • Two Sigma Securities reported no remaining Artelo Biosciences position as of Q2 2022 after selling out during the quarter.
  • Two Sigma Securities sold 68 Artelo Biosciences shares in Q2 2022, an estimated $8K.
  • Two Sigma Securities first reported a position in Artelo Biosciences in Q4 2021 and held it in 2 quarters.
  • Two Sigma Securities's Artelo Biosciences position peaked at $13K in Q4 2021.
  • 15 funds tracked by Wall St. Rank held Artelo Biosciences as of Q2 2022.

Based on Two Sigma Securities's 13F filing for Q2 2022, filed 15 Aug 2022.